Clinical Trials Arena

News, views and contacts from the global Clinical industry
11 January 2019
WEEKLY UPDATE
Digital Magazine
Latest Companies

S-CLINICA

Almac

IntuVigilance

ACTide

Inceptua

Defence forum on LinkedIn


Join our Defence forum on LinkedIn
NRI digital has launched a LinkedIn group to unite professionals involved in the defence and aerospace industry for the opportunity to network and discuss today's most important technologies and issues. Click here if you have a story to tell, a topic to discuss or just want to build contacts.

White Papers

Building The Industry’s Most Advanced Modeling Engine
For the past ten years, the industry has seen an increased demand to determine fair market value of CRO and other clinical trial service providers.

Clinical Trials: Enrollment Trends in Emerging Markets – Russia
Scotty Chung-Siu, Brooke Wilson & Revati Tatake, GlobalData, examine developments in the Russian clinical trial space

Clinical Trials: Enrollment Trends in Emerging Markets – Brazil
In an exclusive white paper, Brooke Wilson, Revati Tatake & Bonnie Bain, GlobalData, assess the clinical trial landscape in Brazil

Clinical Trials: Enrollment Trends in Emerging Markets – South Korea
This whitepaper provides a review of Phase I to Phase IV clinical trials with a start date between January 1, 2001 and June 5, 2018, and which have a trial location in South Korea.

Clinical Trials: Enrollment Trends in Emerging Markets – India
This whitepaper provides a review of the enrollment trends of Phase I to Phase IV clinical trials that had a start date between January 1, 2001 and December 31, 2018 and a trial location in India.

Press Releases

Forty-three Countries Across Five Continents – A Global Pharmacovigilance Company

IntuVigilance win major Pharma Industry Award

Product Selection
There are several forces pushing healthcare professionals to provide patients with personalized medicine, in which treatments are tailored to suit the needs of individual patients.

Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany
New site will support complex clinical research and bring more than 200 new jobs to community

Thermo Fisher Scientific Completes Acquisition of Patheon
WALTHAM, Mass., Aug. 29, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has completed its acquisition of Patheon N.V. (NYSE: PTHN), a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. Today's close follows the expiration of Thermo Fisher's initial tender offer for Patheon at $35.00 per share in cash.

Features

Is the GAIN Act Stimulating Antibiotic R&D?
Christopher J. Pace, PhD, Director of Infectious Diseases, GlobalData, assesses the impact of the GAIN Act

The Top 10: 2018
Clinical Trials Arena highlights the best articles from 2018

Optimizing Technology to Create Patient Centric Trials
Marcin Stefanowicz, Regional Study Manager, Roche, explains why the advent of mobile health technology should be embraced in clinical research

The Future of Pfizer’s $5B Brand is in Jeopardy
Maura Musciacco, MSc, Neurology & Ophthalmology Director, GlobalData, assesses what the future holds for Pfizer’s Lyrica

Strategic Comparator Sourcing – A Matter of High Priority
Ian Hoban, Pilatus Comparator Solutions, poses some key questions that should be front of mind and considered early on in the design of your clinical trial

Projects
Follow Us:   Facebook Facebook    Twitter Twitter    LinkedIn LinkedIn    YouTube YouTube   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Clinical Trials Arena or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.clinicaltrialsarena.com is a product of Kable.
Copyright
2019 Kable, a trading division of Kable Intelligence Limited.